Experience unmatched quality and dependability with Bachem Pharm's manufacturing facilities located in the U.S. Our production processes are carefully aligned with Good Manufacturing Practice (GMP) standards set by regulatory bodies, including the Food and Drug Administration (FDA).
Our peptides API formulations are FDA registered and not affiliated, endorsed, or intended to replace Eli Lilly, Novo Nordisk, or other companies' FDA-approved brands such as Victoza, Saxenda, Byetta, Ozempic, Rybelsus, Wegovy, Adlyxin, Trulicity, or Mounjaro.
Purpose: GLP-1 w/ methylated Pyridoxine, Glycine, NAD+, and B12 is our most successful product! With combined, dual-acting appetite-suppressing properties, users have found the most success.
Bachem Pharma GLP-1 Peptide can be customized with B12 API, Thiamine, Pyridoxine, NAD+, and L-Carnitine. FDA-registered peptides are available for rebranding and for commercial distribution with Vitamin B12-100mcg API. Manufactured with approved DMF according to the Federal Food, Drug, and Cosmetic Act. The NDC number is activated upon order.
A Custom Peptide therapy kit contains:
Customized GLP-1 Injection w/ Vitamin B1 (1000mcg), B6 (1000mcg),B12( 100mcg/mL), L-Carnitine (100mg), and NAD+ (20mg) plus (optional capsule form of 30cts per bottle).
Other Peptides we contract manufacture are:
The addition of other minerals such as methylated forms of Vitamin B1(Thiamin), B6(Pyridoxine), NAD and vitamin B12 is intended to help to improve energy levels, boost metabolism and help burn fat, improve fatigue, muscle loss, or neuropathy—common concerns during weight loss or diabetes treatment—and may offer metabolic, neurological, and musculoskeletal benefits.
Our Customizable APIs are:
Dulaglutide
Tirzepatide
Semaglutide
Retatrutide
Cagrillintide
Exenatide
Bachem Pharma conducts extensive Pre-marketing peptide tests and analytical chemistry on all peptide entities and provides these test reports:
In addition to the above, we provide item reports within 30 days of order, FDA-DMF for ANDA registration or for clinical trials
Bachem Pharm's production facilities are equipped with cutting-edge technology for solvent supply, peptide synthesis, purification, and the isolation of active ingredients and intermediates. With GMP-compliant equipment and validated cleaning procedures, you can be confident in receiving consistent excellence in every batch.
Our formula for success lies in fostering a close partnership with our clients. Through effective collaboration, we tailor process development packages to meet ambitious timelines, delivering phase-appropriate, high-quality products with unmatched efficiency.
Our emphasis is on supplying the components and systems necessary for the delivery of peptide APIs, which are designed to target specific areas within the body, preserve their stability, and improve their effectiveness. For tailored peptides, we offer a variety of specialties for complex conditions, including injectables.
Our diverse capabilities, expert advice, and dedication to quality guarantee smooth scalability, enhanced equipment utilization, and improved efficiency throughout the production process. Collaborating with TirzPharm provides you with:
Diverse production capabilities: This includes solution-phase and solid-phase synthesis reactors, along with innovative methods such as Molecular Modifications.
Smooth scalability: Effortless scalability is achievable with solution-phase reactors reaching up to 8000 litres and solid-phase peptide synthesis (SPPS) reactors up to 500 litres. Larger options are currently under development, with a new facility in Bubendorf offering sizes up to 1000 litres.
Enhanced equipment: Rely on our GMP-qualified equipment, which includes OligoPilot synthesizers and custom-designed cleavage and deprotection equipment trains, ensuring precise control and safety when handling hazardous reagents.
Improved efficiency and quality: Our sophisticated automation and data management systems, featuring a Manufacturing Execution System and a process data historian, enhance efficiency and guarantee superior quality.
Dedication to quality: By adhering to Quality by Design principles and incorporating in-process controls and process analytical technology, we consistently achieve high-quality outcomes.
Bachem Pharm is committed to the ongoing enhancement and modernization of its purification equipment to satisfy the increasing demand for bulk peptide and oligonucleotide pharmaceuticals. In addition, our team will offer you:
Advanced purification methods: Employ a variety of advanced purification techniques, such as preparative high-performance liquid chromatography (HPLC), ion exchange (IEX), size-exclusion chromatography (SEC), and ultra-filtration (UF/TFF). Scalable manufacturing: Our equipment facilitates highly efficient or continuous production of ultra-pure products in multi-kg quantities per batch.
Precise control and scalability: Dynamic axial compression (DAC) stainless steel columns with diameters of up to 60 cm guarantee optimal performance during the separation phase. Stringent microbiological control: ISO 8 and ISO 7 clean rooms equipped with HEPA-filtered air uphold rigorous microbiological control standards.
Safety measures: Down-flow booths reduce microbial contamination, and highly active pharmaceutical ingredients are managed in safety workbenches or isolators rated up to OEB level 4.
Controlled isolation: Meticulously controlled isolation processes, including precipitation, crystallization, and lyophilization of intermediates and final active pharmaceutical ingredients (API), ensure that predefined physicochemical properties are achieved. Multiple lyophilisers for quality assurance: A range of lyophilisers of different sizes ensures product integrity and quality across all batches.
Bachem Pharm has capabilities for the production of GMP small molecules at the site in Texas. We offer:
Good Manufacturing Practices (GMP) are critical standards established by regulatory bodies such as the FDA, EMA, and Swiss Medic. These guidelines ensure that manufacturers follow specific practices to maintain the consistent high quality of their products. Compliance with GMP regulations is necessary for companies to secure authorization and licensing for their manufactured goods.
Continuous chromatography, referred to as Multi-column countercurrent solvent gradient purification (MSCGP), has similarities with HPLC but is distinguished by its fully automated process, the use of multiple columns, and a continuous loading mechanism. This advanced technique guarantees high product yields while preserving purity levels and generally decreases solvent usage, thereby supporting environmentally sustainable chemistry practices.
The large-scale purification of TIDES utilizing Multicolumn Countercurrent Solvent Gradient Purification (MCSGP) under GMP standards ensures the effective and high-quality production of therapeutic peptides. MCSGP enhances the purification process by separating complex mixtures through the use of multiple columns and solvent gradients, thereby improving both purity and yield. When conducted under GMP, this method adheres to rigorous regulatory standards, ensuring that the final product is safe, effective, and appropriate for clinical applications, positioning it as a vital technology for large-scale peptide manufacturing.
Copyright © 2025 USA Tirzepatide Manufacturer - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.